Pulse Biosciences Inc (PLSE)
11.19
+0.18
(+1.63%)
USD |
NASDAQ |
Jun 28, 16:00
11.21
+0.02
(+0.18%)
Pre-Market: 20:00
Pulse Biosciences Cash from Financing (Quarterly): 0.305M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.305M |
| December 31, 2023 | 0.804M |
| September 30, 2023 | 2.149M |
| June 30, 2023 | 13.87M |
| March 31, 2023 | -0.432M |
| December 31, 2022 | -0.017M |
| September 30, 2022 | 65.06M |
| June 30, 2022 | 14.96M |
| March 31, 2022 | -0.065M |
| December 31, 2021 | -0.549M |
| September 30, 2021 | 8.072M |
| June 30, 2021 | 4.004M |
| March 31, 2021 | 51.16M |
| December 31, 2020 | 0.436M |
| September 30, 2020 | 0.426M |
| June 30, 2020 | 29.76M |
| Date | Value |
|---|---|
| March 31, 2020 | 0.264M |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.201M |
| June 30, 2019 | -0.613M |
| March 31, 2019 | 0.494M |
| December 31, 2018 | 44.86M |
| September 30, 2018 | 0.398M |
| June 30, 2018 | -0.063M |
| March 31, 2018 | 0.30M |
| December 31, 2017 | 0.188M |
| September 30, 2017 | 30.01M |
| June 30, 2017 | 0.215M |
| March 31, 2017 | 4.971M |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 20.92M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.549M
Minimum
Dec 2021
65.06M
Maximum
Sep 2022
10.02M
Average
0.436M
Median
Dec 2020
Cash from Financing (Quarterly) Benchmarks
| Align Technology Inc | -11.72M |
| NeuroOne Medical Technologies Corp | 1.960M |
| SINTX Technologies Inc | 5.328M |
| Nutriband Inc | 8.695M |
| enVVeno Medical Corp | 0.046M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -9.78M |
| Cash from Investing (Quarterly) | -0.005M |
| Free Cash Flow | -36.34M |
| Free Cash Flow Per Share (Quarterly) | -0.1774 |
| Free Cash Flow Yield | -6.19% |